CBS Healthcare MBA

[kavita]

Discuss about cbs healthcare MBA here. Welcome to MBA.ind.in and this page is for cbs healthcare MBA discussion. If you are looking for cbs healthcare MBA then ask your question is as much details as possible in the “Quick Reply” box provided below. The more detailed your question will be, the more easy will it be for our experts to answers your query. And if you have any information on cbs healthcare MBA, then please share you knowledge with our viewers in the “Quick Reply” box. You knowledge can help many people. Thanks for stopping by at MBA.ind.in. Please visit again.

Can you provide me the syllabus for - B8221-001: Economics of Healthcare and Pharmaceuticals under Healthcare and Pharmaceutical Management Program (HPM) offered by Columbia Business School of Columbia University?

[sumit]

The syllabus for - B8221-001: Economics of Healthcare and Pharmaceuticals under Healthcare and Pharmaceutical Management Program (HPM) offered by Columbia Business School of Columbia University is as follows:

Course syllabus

The following is an outline of the main topics covered in this course:

Introduction
Warm-up exercise: Investment and pricing decisions in health care: Merck Gardasil case

What price should Merck set for its new vaccine (Gardasil)?
Should a firm develop a vaccine or a drug?
Health insurance
Risk aversion and the social benefits of health insurance; optimal insurance coverage
Moral hazard and the social costs of health insurance

Asymmetric information, adverse selection, and private health insurance market failures; potential remedies
Choice among health plans: health insurance benefit design (optimal premium and copayment structure)

Empirical evidence about the impact of health insurance on the use of medical care

Measuring and valuing health: the quantity, price, and quality of life-years
Longevity, the quantity of life-years
Alternative indicators: life expectancy, premature mortality, cancer survival rate, etc.

Explaining interstate and international variation in longevity growth

The price (value) of life-years: How much should we pay to save a statistical life?
Three alternative approaches: human capital approach, full income approach, and compensating differentials approach
The quality of life-years: Is average quality of life likely to be improved by advances in medicine?